News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2021 AVATAR Supports Early SAVR in Asymptomatic Severe AS Patients L.A. McKeown November 13, 2021
News Conference News AHA 2020 Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib Todd Neale November 14, 2020
News Conference News AHA 2020 TAVR Length of Stay Declines, but Readmissions for New Pacemakers Increase Michael O'Riordan November 10, 2020
News Conference News AHA 2017 More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017